For hundreds of thousands of cancer survivors worldwide, the battle against the disease may have been won...
Clinical Oncology Education
In a breakthrough for oncology, researchers at Rice University, in collaboration with The University of Texas MD...
The 2026 edition of the ESMO Breast Cancer Congress has concluded, leaving behind a profound roadmap for...
A landmark study published in JAMA Network Open has ignited a significant conversation within the oncology community,...
Main Facts: Redefining an Indolent Malignancy Primary cutaneous anaplastic large cell lymphoma (pcALCL) represents a unique challenge...
Glioblastoma (GBM), the most lethal primary brain malignancy, has long frustrated oncologists and researchers. Characterized by aggressive...
The history of melflufen (melphalan flufenamide) in the treatment of relapsed or refractory multiple myeloma (RRMM) serves...
Introduction The 48th San Antonio Breast Cancer Symposium (SABCS), held from December 9–12, 2025, at the Henry...
In the meticulous world of oncological research, where the difference between a successful breakthrough and a failed...
By Medical Science Editorial Staff Published: May 10, 2026 | Source: Cancers (MDPI) The promise of artificial...
